Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phagocytosis‐dependent activation of aTLR9–BTK–calcineurin–NFATpathway co‐ordinates innate immunity toAspergillus fumigatus
Susanne Herbst, Anand Shah, María J. Mazón, et al.
EMBO Molecular Medicine (2015) Vol. 7, Iss. 3, pp. 240-258
Open Access | Times Cited: 167

Showing 1-25 of 167 citing articles:

Aspergillus fumigatus and Aspergillosis in 2019
Jean‐Paul Latgé, Georgios Chamilos
Clinical Microbiology Reviews (2019) Vol. 33, Iss. 1
Open Access | Times Cited: 864
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma
Michail S. Lionakis, Kieron Dunleavy, Mark Roschewski, et al.
Cancer Cell (2017) Vol. 31, Iss. 6, pp. 833-843.e5
Open Access | Times Cited: 443
Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib
David Ghez, Anne Calleja, Caroline Protin, et al.
Blood (2018) Vol. 131, Iss. 17, pp. 1955-1959
Open Access | Times Cited: 264
Call for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways
Georgios Chamilos, Michail S. Lionakis, Dimitrios P. Kontoyiannis
Clinical Infectious Diseases (2017) Vol. 66, Iss. 1, pp. 140-148
Open Access | Times Cited: 247
Bruton’s Tyrosine Kinase: An Emerging Key Player in Innate Immunity
Alexander N.R. Weber, Zsofia Bittner, Xiao Liu, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 244
Comparative Analysis of BTK Inhibitors and Mechanisms Underlying Adverse Effects
H. Yesid Estupiñán, Anna Berglöf, Rula Zain, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 186
The Cell Wall of the Human Fungal Pathogen Aspergillus fumigatus: Biosynthesis, Organization, Immune Response, and Virulence
Jean‐Paul Latgé, Anne Beauvais, Georgios Chamilos
Annual Review of Microbiology (2017) Vol. 71, Iss. 1, pp. 99-116
Open Access | Times Cited: 178
Immune responses to human fungal pathogens and therapeutic prospects
Michail S. Lionakis, Rebecca A. Drummond, Tobias M. Hohl
Nature reviews. Immunology (2023) Vol. 23, Iss. 7, pp. 433-452
Open Access | Times Cited: 167
BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies
Aqu Alu, Hong Lei, Xuejiao Han, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 86
Decoding Toll-like receptors: Recent insights and perspectives in innate immunity
Taro Kawai, Moe Ikegawa, Daisuke Ori, et al.
Immunity (2024) Vol. 57, Iss. 4, pp. 649-673
Open Access | Times Cited: 86
Cryptococcus neoformans Intracellular Proliferation and Capsule Size Determines Early Macrophage Control of Infection
Aleksandra Bojarczuk, Katie A. Miller, Richard Hotham, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 167
Pathogenic Fungal Infection in the Lung
Li Zhi, Gen Lu, Guangxun Meng
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 138
Immunity against fungi
Michail S. Lionakis, Iliyan D. Iliev, Tobias M. Hohl
JCI Insight (2017) Vol. 2, Iss. 11
Open Access | Times Cited: 133
How I manage ibrutinib intolerance and complications in patients with chronic lymphocytic leukemia
Deborah M. Stephens, John C. Byrd
Blood (2019) Vol. 133, Iss. 12, pp. 1298-1307
Open Access | Times Cited: 132
Systematic review of infectious events with the Bruton tyrosine kinase inhibitor ibrutinib in the treatment of hematologic malignancies
Benjamin F. Tillman, James M. Pauff, Gowri Satyanarayana, et al.
European Journal Of Haematology (2017) Vol. 100, Iss. 4, pp. 325-334
Open Access | Times Cited: 126
Ca2+ Signaling but Not Store-Operated Ca2+ Entry Is Required for the Function of Macrophages and Dendritic Cells
Martin Vaeth, Isabelle Zee, Axel R. Concepcion, et al.
The Journal of Immunology (2015) Vol. 195, Iss. 3, pp. 1202-1217
Open Access | Times Cited: 112
Macrophages inhibit Aspergillus fumigatus germination and neutrophil-mediated fungal killing
Emily E. Rosowski, Nicholas Raffa, Benjamin P. Knox, et al.
PLoS Pathogens (2018) Vol. 14, Iss. 8, pp. e1007229-e1007229
Open Access | Times Cited: 107
Ibrutinib blocks Btk-dependent NF-ĸB and NFAT responses in human macrophages during Aspergillus fumigatus phagocytosis
Amelia Bercusson, Thomas Colley, Anand Shah, et al.
Blood (2018) Vol. 132, Iss. 18, pp. 1985-1988
Open Access | Times Cited: 105
Characterization of Aspergillus fumigatus Isolates from Air and Surfaces of the International Space Station
Benjamin P. Knox, Adriana Blachowicz, Jonathan Palmer, et al.
mSphere (2016) Vol. 1, Iss. 5
Open Access | Times Cited: 101
Antifungal Innate Immunity: A Perspective from the Last 10 Years
Fabián Salazar, Gordon D. Brown
Journal of Innate Immunity (2018) Vol. 10, Iss. 5-6, pp. 373-397
Open Access | Times Cited: 101
Phagosomal removal of fungal melanin reprograms macrophage metabolism to promote antifungal immunity
Samuel M. Gonçalves, Cláudio Duarte‐Oliveira, Cláudia F. Campos, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 91
The role of Bruton's tyrosine kinase in the immune system and disease
Charlotte McDonald, Charalampos Xanthopoulos, Efterpi Kostareli
Immunology (2021) Vol. 164, Iss. 4, pp. 722-736
Open Access | Times Cited: 86
During Aspergillus Infection, Monocyte-Derived DCs, Neutrophils, and Plasmacytoid DCs Enhance Innate Immune Defense through CXCR3-Dependent Crosstalk
Yahui Guo, Shinji Kasahara, Anupam Jhingran, et al.
Cell Host & Microbe (2020) Vol. 28, Iss. 1, pp. 104-116.e4
Open Access | Times Cited: 73
Targeting Bruton’s Tyrosine Kinase in CLL
Inhye E. Ahn, Jennifer R. Brown
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 69
Inhibition of Bruton’s Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer’s Disease
James Keaney, Julien Gasser, Gaëlle Gillet, et al.
Journal of Neuroimmune Pharmacology (2019) Vol. 14, Iss. 3, pp. 448-461
Open Access | Times Cited: 73
Page 1 - Next Page

Scroll to top